Basaglar Side Effects: What to Expect and When to Call Your Doctor

Like all insulin products, Basaglar (insulin glargine injection) carries the potential for side effects — some minor and manageable, others requiring immediate medical attention. Understanding what to expect helps you stay safe and catch problems early. Here is a complete overview of Basaglar's side effect profile.

The Most Common Side Effect: Hypoglycemia (Low Blood Sugar)

By far the most common — and most serious — side effect of Basaglar is hypoglycemia (low blood sugar). It can occur when your Basaglar dose is higher than your body needs, if you skip a meal or eat less than usual, or if you exercise more than normal.

Signs of Low Blood Sugar to Know

Mild to moderate hypoglycemia symptoms include:

• Shakiness or trembling
• Sweating (not from heat)
• Dizziness or lightheadedness
• Rapid heartbeat
• Hunger (sudden and intense)
• Headache or difficulty concentrating
• Blurry vision
• Irritability or anxiety

Treat mild hypoglycemia immediately with 15–20 grams of fast-acting carbohydrates (such as 4 glucose tablets, 4 oz of juice, or regular soda — not diet). Recheck your blood sugar after 15 minutes.

Severe Hypoglycemia: When to Call 911

Severe hypoglycemia is a medical emergency. Call 911 or have someone administer glucagon immediately if the person with diabetes is:

• Unconscious or unresponsive
• Having a seizure
• Severely confused or speaking incoherently
• Unable to swallow safely

Because Basaglar is a long-acting insulin, hypoglycemia may be prolonged and can recur after initial treatment. Monitor closely for several hours after a severe episode.

Common Side Effects of Basaglar (≥5% Incidence)

Beyond hypoglycemia, these side effects occur in at least 5% of Basaglar patients in clinical trials:

• Injection site reactions: Redness, pain, itching, bruising, or thickening of skin at the injection site. Rotating injection sites helps prevent lipodystrophy (fatty tissue changes).
• Lipodystrophy: Pitting or thickening of skin from repeated injections in the same spot. Always rotate injection sites.
• Weight gain: Insulin has anabolic effects that can cause modest weight gain, especially in the first months of therapy. Discuss dietary adjustments with your provider if this occurs.
• Edema (swelling): Mild swelling, especially in the legs or ankles, can occur when starting insulin therapy. Usually resolves over time.
• Allergic reactions: Mild allergic reactions (rash, itching) at the injection site or elsewhere.

Serious Side Effects: When to Seek Immediate Care

Call 911 or go to the emergency room if you experience any of the following:

• Severe allergic reaction (anaphylaxis): Difficulty breathing, swelling of face/throat/tongue, severe rash, rapid heartbeat. Discontinue Basaglar and seek emergency care immediately.
• Severe hypokalemia (low potassium): Muscle cramps, weakness, irregular heartbeat. Insulin can cause potassium to shift into cells, lowering blood potassium dangerously. Risk is highest in patients with existing kidney disease or on diuretics.
• Heart failure symptoms (if on TZD medications): Basaglar combined with thiazolidinediones (pioglitazone, rosiglitazone) can worsen or cause heart failure. Report any sudden weight gain, swelling, or shortness of breath immediately.

Important Safety Reminders

• Never inject Basaglar into a vein or muscle — subcutaneous injection only.
• Never mix Basaglar with any other insulin or solution.
• Never use Basaglar in an insulin pump.
• Never share your KwikPen with another person — risk of blood-borne pathogen transmission.
• Always check the pen label before each injection — mix-ups with rapid-acting insulins have occurred.

Understanding drug interactions is also crucial for Basaglar safety — see our guide on Basaglar drug interactions. And if you need help finding Basaglar in stock, medfinder calls pharmacies near you to check availability.